Semprus BioSciences, a subsidiary of Teleflex, has received CE mark for its Nylus peripherally inserted central catheter (PICC) with Semprus Sustain technology from its notified body, the Netherlands-based DEKRA Certification Group.
The Nylus PICC uses a polymer which is designed to reduce the attachment of platelets and blood proteins at the surface of the device.
In-vitro and animal testing of the Nylus PICC has shown to reduce platelet adhesion and thrombus accumulation.
Teleflex Semprus technology strategic and business development vice president David Lucchino said the clearance enables the company to further advance a new standard of care in PICC catheters.
"Our novel technology, with its ability to work in blood products and long-term duration, holds great potential to reduce infection and thrombus-related complications for patients – while substantially decreasing associated healthcare costs," Lucchino added.